BerGenBio Announces First Patient Entered Into Advanced Adenocarcinoma Lung Cancer Trial ...Middle East

BERGEN, Norway, Jan. 7, 2025 /PRNewswire/ -- BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing the novel, selective AXL kinase inhibitor bemcentinib for lung cancer announced today that the first patient has been included in a clinical trial sponsored by...

Hence then, the article about bergenbio announces first patient entered into advanced adenocarcinoma lung cancer trial was published today ( Tuesday 07/01/2025 - 09:29 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( BerGenBio Announces First Patient Entered Into Advanced Adenocarcinoma Lung Cancer Trial )

Also on site :

• Robert Reed’s Daughter, Who Appeared on 'The Brady Bunch', Dies at 69
• Canada Dry Brings Back Popular Flavor That Once Flew off Shelves
• '90s Rocker Announces Update on First Solo Album 26 Years After Leaving Band